LifeStance Health Group, Inc. Other Comprehensive Income (Loss), Net of Tax
LifeStance Health Group, Inc. (LFST) reported Other Comprehensive Income (Loss), Net of Tax of -$929.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-06
- LifeStance Health Group, Inc. other comprehensive income (loss), net of tax for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- LifeStance Health Group, Inc. other comprehensive income (loss), net of tax for the quarter ending 2025-09-30 was -$345.00K.
- LifeStance Health Group, Inc. other comprehensive income (loss), net of tax for the quarter ending 2025-06-30 was -$267.00K.
- LifeStance Health Group, Inc. other comprehensive income (loss), net of tax for the quarter ending 2025-03-31 was -$317.00K, a 154.37% decline year-over-year.
- LifeStance Health Group, Inc. other comprehensive income (loss), net of tax for fiscal 2025 was -$929.00K.
- LifeStance Health Group, Inc. other comprehensive income (loss), net of tax for fiscal 2024 was -$1.37M.
- LifeStance Health Group, Inc. other comprehensive income (loss), net of tax for fiscal 2023 was -$971.00K, a 129.66% decline from fiscal 2022.
- LifeStance Health Group, Inc. other comprehensive income (loss), net of tax for fiscal 2022 was $3.27M.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$345.00K derived: sum of 2 quarters · filed 2026-02-25 | -$612.00K derived: sum of 3 quarters · filed 2026-08-06 | -$929.00K 10-K · filed 2026-02-25 |
| 2025-09-30 | -$345.00K 10-Q · filed 2025-11-06 | -$612.00K derived: sum of 2 quarters · filed 2026-08-06 | -$929.00K 10-Q · filed 2025-11-06 | -$771.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$267.00K 10-Q · filed 2026-08-06 | -$584.00K 10-Q · filed 2026-08-06 | -$426.00K derived: sum of 3 quarters · filed 2026-08-06 | -$2.30M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$317.00K 10-Q · filed 2026-05-07 | -$159.00K derived: sum of 2 quarters · filed 2026-05-07 | -$2.03M derived: sum of 3 quarters · filed 2026-05-07 | -$2.27M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $158.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$1.71M derived: sum of 2 quarters · filed 2026-02-25 | -$1.96M derived: sum of 3 quarters · filed 2026-02-25 | -$1.37M 10-K · filed 2026-02-25 |
| 2024-09-30 | -$1.87M 10-Q · filed 2025-11-06 | -$2.12M derived: sum of 2 quarters · filed 2025-11-06 | -$1.53M 10-Q · filed 2025-11-06 | -$3.61M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | -$243.00K 10-Q · filed 2025-08-07 | $340.00K 10-Q · filed 2025-08-07 | -$1.74M derived: sum of 3 quarters · filed 2026-02-25 | -$1.51M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $583.00K 10-Q · filed 2025-05-07 | -$1.50M derived: sum of 2 quarters · filed 2026-02-25 | -$1.26M derived: sum of 3 quarters · filed 2026-02-25 | $882.00K derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | -$2.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$1.85M derived: sum of 2 quarters · filed 2026-02-25 | $299.00K derived: sum of 3 quarters · filed 2026-02-25 | -$971.00K 10-K · filed 2026-02-25 |
| 2023-09-30 | $230.00K 10-Q · filed 2024-11-07 | $2.38M derived: sum of 2 quarters · filed 2024-11-07 | $1.11M 10-Q · filed 2024-11-07 | $1.20M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $2.15M 10-Q · filed 2024-08-08 | $877.00K 10-Q · filed 2024-08-08 | $966.00K derived: sum of 3 quarters · filed 2025-02-27 | $4.15M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$1.27M 10-Q · filed 2024-05-09 | -$1.18M derived: sum of 2 quarters · filed 2025-02-27 | $2.00M derived: sum of 3 quarters · filed 2025-02-27 | |
| 2022-12-31 | $89.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $3.27M derived: sum of 2 quarters · filed 2025-02-27 | $3.27M 10-K · filed 2025-02-27 | |
| 2022-09-30 | $3.19M 10-Q · filed 2023-11-08 | $3.19M 10-Q · filed 2023-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |